atherosclerosis
Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
Troglitazone inhibits <span class="disease" id="11231916-0-22-37">atherosclerosis</span> in <span class="gene" id="11231916-0-41-57">apolipoprotein E</span>-knockout mice: pleiotropic effects on CD36 expression and HDL.